Correlation Between PDS Biotechnology and Icosavax
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Icosavax, you can compare the effects of market volatilities on PDS Biotechnology and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Icosavax.
Diversification Opportunities for PDS Biotechnology and Icosavax
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between PDS and Icosavax is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Icosavax go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Icosavax
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Icosavax. But the stock apears to be less risky and, when comparing its historical volatility, PDS Biotechnology Corp is 1.22 times less risky than Icosavax. The stock trades about -0.04 of its potential returns per unit of risk. The Icosavax is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 850.00 in Icosavax on August 31, 2024 and sell it today you would earn a total of 52.00 from holding Icosavax or generate 6.12% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 28.45% |
Values | Daily Returns |
PDS Biotechnology Corp vs. Icosavax
Performance |
Timeline |
PDS Biotechnology Corp |
Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
PDS Biotechnology and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PDS Biotechnology and Icosavax
The main advantage of trading using opposite PDS Biotechnology and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |